Marsico Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Marsico Capital Management's BIIB Position: Q1 2019 in Review
Marsico Capital Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 97,272 shares — an estimated $29.3M sold.
Marsico Capital Management first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $860M in Q2 2013. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.
- Marsico Capital Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
- Marsico Capital Management sold 97,272 Biogen shares in Q1 2019, an estimated $29.3M.
- Marsico Capital Management first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
- Marsico Capital Management's Biogen position peaked at $860M in Q2 2013.
- 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.
Based on Marsico Capital Management's 13F filing for Q1 2019, filed 15 May 2019.